Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lung cancer biopsies: Comparison between simple 22G, 22G upgraded and 21G needle for EBUS-TBNA.
Zarogoulidis P, Petridis D, Sapalidis K, Tsakiridis K, Baka S, Vagionas A, Hohenforst-Schmidt W, Freitag L, Huang H, Bai C, Drougas D, Theofilatou V, Romanidis K, Perdikouri EI, Petanidis S, Zaric B, Kovacevic T, Stojsic V, Sarcev T, Bursac D, Kukic B, Perin B, Courcoutsakis N, Athanasiou E, Hatzibougias D, Drevelegas K, Boukovinas I, Kosmidou M, Kosmidis C. Zarogoulidis P, et al. Among authors: bursac d. J Cancer. 2020 Sep 14;11(21):6454-6459. doi: 10.7150/jca.48691. eCollection 2020. J Cancer. 2020. PMID: 33033529 Free PMC article.
Connection between PD-L1 expression and standardized uptake value in NSCLC: an early prognostic treatment combination.
Zarogoulidis P, Christakidis V, Petridis D, Sapalidis K, Kosmidis C, Vagionas A, Perdikouri EI, Hohenforst-Schmidt W, Huang H, Petanidis S, Tsakiridis K, Baka S, Romanidis K, Zaric B, Kovacevic T, Stojsic V, Sarcev T, Bursac D, Kukic B, Boukovinas I, Tolis C, Sardeli C. Zarogoulidis P, et al. Among authors: bursac d. Expert Rev Respir Med. 2021 May;15(5):675-679. doi: 10.1080/17476348.2021.1859373. Epub 2020 Dec 31. Expert Rev Respir Med. 2021. PMID: 33275458
Thyroid cancer diagnosis with transdermal probe 22G U/S versus EBUS-convex probe TBNA-B 22G and 19G: pros and cons.
Zarogoulidis P, Huang H, Zhou J, Ning Y, Yang M, Wang J, Zhang R, Bai C, Shen X, Huang Z, Petridis D, Kosmidis C, Kosmidou M, Tsakiridis K, Hohenforst-Schmidt W, Baka S, Petanidis S, Zaric B, Kovacevic T, Stojsic V, Sarcev T, Bursac D, Kukic B, Rapti A, Pantea S, Rogoveanu O, Rogoveanu I, Romanidis K, Kesisoglou I, Ioannidis A, Vagionas A, Sapalidis K. Zarogoulidis P, et al. Among authors: bursac d. Expert Rev Med Devices. 2021 Feb;18(2):197-201. doi: 10.1080/17434440.2021.1880891. Epub 2021 Jan 29. Expert Rev Med Devices. 2021. PMID: 33482695
Intratumoral Treatment with Chemotherapy and Immunotherapy for NSCLC with EBUS-TBNA 19G.
Zarogoulidis P, Hohenforst-Schmidt W, Huang H, Zhou J, Wang Q, Wang X, Xia Y, Ding Y, Bai C, Kosmidis C, Sapalidis K, Sardeli C, Tsakiridis K, Zaric B, Kovacevic T, Stojsic V, Sarcev T, Bursac D, Kukic B, Baka S, Athanasiou E, Hatzibougias D, Michalopoulou-Manoloutsiou E, Petanidis S, Drougas D, Drevelegas K, Paliouras D, Barbetakis N, Vagionas A, Freitag L, Lallas A, Boukovinas I, Petridis D, Ioannidis A, Matthaios D, Romanidis K, Karapantzou C. Zarogoulidis P, et al. Among authors: bursac d. J Cancer. 2021 Mar 5;12(9):2560-2569. doi: 10.7150/jca.55322. eCollection 2021. J Cancer. 2021. PMID: 33854617 Free PMC article.
Personalized Approach to Tissue and Liquid Biopsy after Failure of First-Line EGFR-TKIs: Is There an Issue When Tissue Is Not the Issue? A Case Series.
Bursac D, Zarić B, Kovačević T, Stojšić V, Vagionas A, Boukovinas I, Tsakiridis K, Kosmidis C, Sapalidis K, Romanidis K, Courcoutsakis N, Matthaios D, Zarogoulidis P, Sardeli C, Sekerus V. Bursac D, et al. Case Rep Oncol. 2021 May 10;14(2):716-724. doi: 10.1159/000515506. eCollection 2021 May-Aug. Case Rep Oncol. 2021. PMID: 34177521 Free PMC article.
Long Term Respiratory Follow-Up for COVID-19 Patients a Multicenter Study.
Bursac D, Petridis D, Zaric B, Kovacevic T, Stojsic V, Sarcev T, Huang H, Bai C, Hohenforst-Schmidt W, Kosmidis C, Sapalidis K, Romanidis K, Courcoutsakis N, Lallas A, Tsakaldimis G, Chatzimichael K, Sardeli C, Matthaios D, Zarogoulidis P, Karapantzou C. Bursac D, et al. Curr Health Sci J. 2021 Oct-Dec;47(4):507-515. doi: 10.12865/CHSJ.47.04.05. Epub 2021 Dec 31. Curr Health Sci J. 2021. PMID: 35444815 Free PMC article.
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.
Horn L, Mansfield AS, Szczęsna A, Havel L, Krzakowski M, Hochmair MJ, Huemer F, Losonczy G, Johnson ML, Nishio M, Reck M, Mok T, Lam S, Shames DS, Liu J, Ding B, Lopez-Chavez A, Kabbinavar F, Lin W, Sandler A, Liu SV; IMpower133 Study Group. Horn L, et al. N Engl J Med. 2018 Dec 6;379(23):2220-2229. doi: 10.1056/NEJMoa1809064. Epub 2018 Sep 25. N Engl J Med. 2018. PMID: 30280641 Clinical Trial.
31 results